- Home
- ADXN vs PMAX Comparison
ADXN vs PMAX Comparison
Compare ADXN & PMAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADXN
- PMAX
- Stock Information
- Founded
- ADXN 2002
- PMAX 2019
- Country
- ADXN Switzerland
- PMAX Hong Kong
- Employees
- ADXN N/A
- PMAX N/A
- Industry
- ADXN Biotechnology: Pharmaceutical Preparations
- PMAX
- Sector
- ADXN Health Care
- PMAX
- Exchange
- ADXN Nasdaq
- PMAX Nasdaq
- Market Cap
- ADXN 8.0M
- PMAX 6.7M
- IPO Year
- ADXN N/A
- PMAX 2024
- Fundamental
- Price
- ADXN $10.70
- PMAX $0.31
- Analyst Decision
- ADXN Strong Buy
- PMAX
- Analyst Count
- ADXN 1
- PMAX 0
- Target Price
- ADXN $30.00
- PMAX N/A
- AVG Volume (30 Days)
- ADXN 58.4K
- PMAX 2.1M
- Earning Date
- ADXN 09-01-2025
- PMAX 10-17-2025
- Dividend Yield
- ADXN N/A
- PMAX N/A
- EPS Growth
- ADXN N/A
- PMAX N/A
- EPS
- ADXN 0.10
- PMAX N/A
- Revenue
- ADXN $278,508.00
- PMAX $4,694,079.00
- Revenue This Year
- ADXN $86.57
- PMAX N/A
- Revenue Next Year
- ADXN N/A
- PMAX N/A
- P/E Ratio
- ADXN $0.85
- PMAX N/A
- Revenue Growth
- ADXN N/A
- PMAX N/A
- 52 Week Low
- ADXN $6.51
- PMAX $0.23
- 52 Week High
- ADXN $12.05
- PMAX $4.60
- Technical
- Relative Strength Index (RSI)
- ADXN 78.58
- PMAX 45.17
- Support Level
- ADXN $7.70
- PMAX $0.23
- Resistance Level
- ADXN $8.21
- PMAX $0.33
- Average True Range (ATR)
- ADXN 0.22
- PMAX 0.05
- MACD
- ADXN 0.20
- PMAX 0.00
- Stochastic Oscillator
- ADXN 68.97
- PMAX 32.48
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.
About PMAX Powell Max Limited Class A Ordinary Shares
Powell Max Ltd is an financial communications services provider. Its financial communications services cover a full range of financial printing, corporate reporting, communications and language support services from inception to completion, including typesetting, proofreading, translation, design, printing, electronic reporting, newspaper placement and distribution. It operates in a single business segment which is the provision of corporate financial communications and financial printing services. All operations are carried in Hong Kong.